Expertise in
16
conditions

Dr. Elizabeth Riley

Hematology
Uofl Health-Brown Cancer Center
529 S Jackson St, 
Louisville, KY 
Expertise in
16
conditions
Uofl Health-Brown Cancer Center
529 S Jackson St, 
Louisville, KY 

Overview

Elizabeth Riley is a Hematologist practicing medicine in Louisville, Kentucky.

Dr. Riley is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Paget Disease of the Breast.

She is actively involved in clinical research, co-authoring 56 peer reviewed articles and participating in 6 clinical trials.

Specialties

Hematology

Licenses

Internal Medicine in MA

Hospital Affiliations

University Of Louisville Hospital
Norton Hospitals, Inc
UOFL HEALTH - JEWISH HOSPITAL And Mary & Elizabeth Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Uofl Health-Brown Cancer Center
529 S Jackson St, Louisville, KY 40202
Other Locations
Uofl Health-Brown Cancer Center-Blood Cancer, Cellular Therapeutics And Transplant Program
2401 Terra Crossing Blvd Ste 200, Louisville, KY 40245

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Single Arm, Open Label Phase 2 Study of Tucatinib in Combination With Trastuzumab Deruxtecan in Subjects With Previously Treated Unresectable Locally-Advanced or Metastatic HER2+ Breast Cancer
A Single Arm, Open Label Phase 2 Study of Tucatinib in Combination With Trastuzumab Deruxtecan in Subjects With Previously Treated Unresectable Locally-Advanced or Metastatic HER2+ Breast Cancer
Enrollment Status: Completed
Publish Date: March 23, 2026
Intervention Type: Drug
Study Drugs: tucatinib, trastuzumab deruxtecan
Study Phase: Phase 2
An Open-Label, Randomized, Multicenter Study Evaluating the Activity of Lasofoxifene Relative to Fulvestrant for the Treatment of Pre- and Postmenopausal Women With Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
An Open-Label, Randomized, Multicenter Study Evaluating the Activity of Lasofoxifene Relative to Fulvestrant for the Treatment of Pre- and Postmenopausal Women With Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Enrollment Status: Completed
Publish Date: January 28, 2026
Intervention Type: Drug
Study Drugs: Lasofoxifene, Fulvestrant
Study Phase: Phase 2
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
Extended Interval Port Flushes: A Phase II Clinical Trial
Extended Interval Port Flushes: A Phase II Clinical Trial
Enrollment Status: Completed
Publish Date: July 19, 2021
Intervention Type: Other
Study Phase: Phase 2
A Phase 1/2 Open-Label Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Seviteronel in Subjects With Advanced Breast Cancer
A Phase 1/2 Open-Label Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Seviteronel in Subjects With Advanced Breast Cancer
Enrollment Status: Completed
Publish Date: February 01, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Predicting Adverse Cardiac Events in Breast Cancer Therapy (PACE in Breast Cancer)
Predicting Adverse Cardiac Events in Breast Cancer Therapy (PACE in Breast Cancer)
Enrollment Status: Completed
Publish Date: February 19, 2018
Intervention Type: Other, Procedure, Genetic, Biological, Drug
View 5 Less Clinical Trials

56 Total Publications

Barriers and Facilitators Impacting Return-to-Work Reported by People with Poststroke Aphasia.
Barriers and Facilitators Impacting Return-to-Work Reported by People with Poststroke Aphasia.
Journal: Seminars in speech and language
Published: December 16, 2025
Similar Doctors
Expertise in
12
conditions
Dr. Goetz Kloecker
Hematology
Expertise in
12
conditions
Dr. Goetz Kloecker
Hematology

Uofl Health-Brown Cancer Center

529 S Jackson St, 
Louisville, KY 
 (0.1 miles away)
502-562-4673
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Goetz Kloecker is a Hematologist practicing medicine in Louisville, Kentucky. Dr. Kloecker is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Gastrostomy.

Expertise in
74
conditions
Dr. Michael Kommor
Hematology | Oncology
Expertise in
74
conditions
Dr. Michael Kommor
Hematology | Oncology

Baptist Health Lagrange Kresge Pharmacy

4003 Kresge Way Ste 500, 
Louisville, KY 
 (5.0 miles away)
502-897-1166
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Michael Kommor is a Hematologist and an Oncologist practicing medicine in Louisville, Kentucky. Dr. Kommor is highly rated in 74 conditions, according to our data. His clinical expertise encompasses Splenic Neoplasm, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Lung Cancer.

Expertise in
131
conditions
Dr. Naveed Chowhan
Hematology | Oncology
Expertise in
131
conditions
Dr. Naveed Chowhan
Hematology | Oncology

Floyd Memorial Hospital And Health Services

2210 Green Valley Rd, 
New Albany, IN 
 (6.3 miles away)
812-284-4771
Languages Spoken:
English
See accepted insurances

Naveed Chowhan is a Hematologist and an Oncologist practicing medicine in New Albany, Indiana. Dr. Chowhan is highly rated in 131 conditions, according to our data. His clinical expertise encompasses Hemangioma Thrombocytopenia Syndrome, Thrombocytopenia, Non-Hodgkin Lymphoma, Congenital Antithrombin 3 Deficiency, and Bone Marrow Aspiration.

Frequently Asked Questions about Dr. Elizabeth Riley

How do I make an appointment with Dr. Elizabeth Riley?

You can book an appointment with Dr. Elizabeth Riley by calling their office at 502-562-4673. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Elizabeth Riley a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Elizabeth Riley is classified as an Elite expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Elizabeth Riley specialize in?

While Dr. Elizabeth Riley is a Hematology, they have specific expertise in Breast Cancer, Angiosarcoma, and Inflammatory Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Elizabeth Riley participate in research or clinical trials?

Yes. Dr. Elizabeth Riley has published 56 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Elizabeth Riley's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Elizabeth Riley accept my insurance?

Dr. Elizabeth Riley accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 502-562-4673 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Riley's expertise for a condition
ConditionClose
View All 12 Advanced Conditions
View All 34 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile